Page last updated: 2024-08-24

emtricitabine and quad pill

emtricitabine has been researched along with quad pill in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (85.71)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Belavic, JM1
Arribas, JR; Bender, R; Garner, W; Gathe, J; Nguyen, T; Shreay, S; Speck, RM; Van Lunzen, J1
Angione, SA; Cherian, SM; Özdener, AE1
Bauer, U; Bobardt, J; Iakoubov, R; Schmid, RM; Schneider, J; Schulz, S; Spinner, CD; Von Werder, A; Wolf, E; Zink, A1
Bugnon, S; Godinho, R; Gracin, T; Tataw, J1
Berry, E; Covaci, A; Gys, C; Heytens, L; Jacobs, W; Lambert, W; Meskal, A; Mortelé, O; Neels, H; Schouwers, S; Van Hemeldonck, E; van Nuijs, ALN; van Rafelghem, B1

Reviews

1 review(s) available for emtricitabine and quad pill

ArticleYear
A Review of the Efficacy and Safety of Genvoya® (Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide) in the Management of HIV-1 Infection.
    Journal of pharmacy practice, 2018, Volume: 31, Issue:2

    Topics: Anti-HIV Agents; Clinical Trials, Phase III as Topic; Cobicistat; Diarrhea; Disease Management; Drug Combinations; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Emtricitabine; Headache; HIV Infections; HIV-1; Humans; Nausea; Quinolones; Randomized Controlled Trials as Topic; Tenofovir; Treatment Outcome

2018

Trials

2 trial(s) available for emtricitabine and quad pill

ArticleYear
Patient-Reported Symptoms over 48 Weeks in a Randomized, Open-Label, Phase 3b Non-inferiority Trial of Adults with HIV Switching to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir DF Versus Continuation of Ritonavir-Boosted Protease In
    The patient, 2015, Volume: 8, Issue:5

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Combinations; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Emtricitabine; Female; HIV Infections; Humans; Logistic Models; Male; Patient Outcome Assessment; Patient Satisfaction; Protease Inhibitors; Ritonavir; Tenofovir

2015
Effects of antiretroviral combination therapies F/TAF, E/C/F/TAF and R/F/TAF on insulin resistance in healthy volunteers: the TAF-IR Study.
    Antiviral therapy, 2018, Volume: 23, Issue:7

    Topics: Adenine; Adult; Anti-HIV Agents; Blood Glucose; Body Weight; Drug Combinations; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Emtricitabine; Glucose Clamp Technique; Healthy Volunteers; Humans; Insulin Resistance; Male; Prospective Studies; Rilpivirine; Tenofovir

2018

Other Studies

4 other study(ies) available for emtricitabine and quad pill

ArticleYear
Drug updates and approvals: 2012 in review.
    The Nurse practitioner, 2013, Feb-10, Volume: 38, Issue:2

    Topics: Acetanilides; Adenine; Antibodies, Monoclonal, Humanized; Benzazepines; Carbamates; Cobicistat; Deoxycytidine; Drug Approval; Drug Combinations; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Emtricitabine; Fatty Alcohols; Humans; Mifepristone; Nicotinic Acids; Nurse Practitioners; Organophosphonates; Phosphatidylglycerols; Prednisone; Proteins; Pyrimidines; Quinolones; Ranibizumab; Tenofovir; Thiazoles; United States; United States Food and Drug Administration

2013
Genvoya--a new 4-drug combination for HIV.
    The Medical letter on drugs and therapeutics, 2016, Feb-15, Volume: 58, Issue:1488

    Topics: Cobicistat; Drug Combinations; Drug Interactions; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Emtricitabine; HIV Infections; HIV Integrase Inhibitors; HIV-1; Humans; Quinolones; Randomized Controlled Trials as Topic; Tenofovir; Treatment Outcome

2016
Severe rhabdomyolysis-induced acute kidney injury following concomitant use of Genvoya® (EVG/COBI/FTC/TAF) and simvastatin; a case report.
    BMC nephrology, 2019, 02-26, Volume: 20, Issue:1

    Topics: Acute Kidney Injury; Anti-HIV Agents; Cobicistat; Drug Combinations; Drug Interactions; Dyslipidemias; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Emtricitabine; Hepatitis A; Hepatitis C; HIV Infections; Humans; Hypolipidemic Agents; Liver Function Tests; Male; Middle Aged; Quinolones; Renal Dialysis; Rhabdomyolysis; Simvastatin; Tenofovir; Treatment Outcome

2019
Overdose of the HIV Medicine Genvoya® in Two Auto-Intoxications.
    Journal of analytical toxicology, 2023, Feb-21, Volume: 47, Issue:1

    Topics: Anti-HIV Agents; Drug Combinations; Drug Overdose; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Emtricitabine; HIV; HIV Infections; Humans

2023